Employee Number: 101-250
Investors Number: 17
Funding Status: IPO
Headquarters: Hayward, California, United States
Technology: Anti-infective Drugs
Estimated Revenue: $1M to $10M
Founded Date: 2015
Last Funding Type: Series C
Investor Type: N/A
Total Funding: $226.7M
Number Of Exists: N/A
Investment Stage: N/A
Industry: PharmTech